Remove Definition Remove Genetics and mental health Remove Pharmaceuticals
article thumbnail

Undisclosed Financial Conflicts of Interest in the DSM-5: An Interview with Lisa Cosgrove and Brian Piper

Mad in America

Mad in America has previously examined the problems with conflicts of interest in research but this time we extend that to look at the potential effect of COIs on diagnostic tools such as the Diagnostic and Statistical Manual of Mental Disorders (DSM). Cosgrove: Definitely. He was also a major user for an extended period.

article thumbnail

Is Madness an Evolved Signal? Justin Garson on Strategy Versus Dysfunction

Mad in America

You’re also an author, and you’ve written on topics such as aging, genetics, mental representation, biological functions, mechanisms in science, and the concept of information in neuroscience. So why do we call schizophrenia a mental disorder, but not believing in conspiracy theories?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Chemically Imbalanced: Joanna Moncrieff on the Making and Unmaking of the Serotonin Myth

Mad in America

Dr. Moncrieff is a psychiatrist who works in the National Health Service in the United Kingdom. Moncrieff: When I was in medical school we were taught, as we’re still officially taught now, the biopsychosocial model of mental disorders. Whitaker: So now you go out and you’re in the asylum or mental hospital.

article thumbnail

Branding Diseases—How Drug Companies Market Psychiatric Conditions: An Interview with Ray Moynihan

Mad in America

R ay Moynihan is an accomplished health journalist and author who has won several awards for his work. For the pharmaceutical industry, the bigger and wider those diseases, the more people who can be diagnosed, and the bigger your markets are. This applies in the mental illness world and everywhere in medicine.

article thumbnail

Part 4: Neurodiversity: New Paradigm, or Trojan Horse?

Mad in America

Within this, some parts of the neurodiversity movement take an uncritical or neutral perspective on the validity of psychiatric diagnoses such as—but not limited to—ASD and ADHD, backed up by unsubstantiated claims about biological and genetic causal factors. This heterogeneity makes it difficult to generalise.

article thumbnail

May Cause Side Effects–Radical Acceptance and Psychiatric Drug Withdrawal: An Interview with Brooke Siem

Mad in America

Moore: We’re here to talk about some of your experiences of the mental health system and polypharmacy, experiences which are beautifully captured in your book, May Cause Side Effects , published by Central Recovery Press in 2022. Thank you so much for joining me today for the Mad In America podcast. Everything is so reactive.

article thumbnail

“All Real Living Is Meeting”: Brent Robbins on Love, Death, and the Possibilities of Psychology

Mad in America

His work spans everything from the cultural history of mental illness to mindfulness, death anxiety, and resiliencenot the hollow kind that comes from pretending everythings fine, but the kind that comes from staring into the void and refusing to flinch. On a personal note, Brent has played a foundational role in my own journey.